Sabarubicin

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Sabarubicin
Sabarubicin.svg
Clinical data
ATC code
  • none
Identifiers
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
Formula C32H37NO13
Molar mass 643.64 g/mol
3D model (JSmol)

Sabarubicin (MEN-10755), a disaccharide analog of doxorubicin, is used for the treatment of small cell lung cancer (SCLC).[1] It has been seen to show superior antitumour efficacy, which is purported to be linked to the activation of p53-independent apoptosis.[2]

References[edit]